학술논문
Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination.
Document Type
Article
Author
Evonuk, Kirsten Scarlett; Wang, Sen; Mattie, Josh; Cracchiolo, C. J.; Mager, Reine; Ferenčić, Željko; Sprague, Ethan; Carrier, Brandon; Schofield, Kai; Martinez, Evelyn; Stewart, Zachary; Petrosino, Tara; Johnson, Gregory Andrew; Yusuf, Isharat; Plaisted, Warren; Naiman, Zachary; Delp, Timothy; Carter, Laura; Marušić, Suzana
Source
Subject
*BRUTON tyrosine kinase
*DEMYELINATION
*MYELOID cells
*CELLULAR control mechanisms
*SMALL molecules
*
*
*
*
Language
ISSN
2051-5960
Abstract
Bruton's tyrosine kinase (BTK) is an emerging target in multiple sclerosis (MS). Alongside its role in B cell receptor signaling and B cell development, BTK regulates myeloid cell activation and inflammatory responses. Here we demonstrate efficacy of BTK inhibition in a model of secondary progressive autoimmune demyelination in Biozzi mice with experimental autoimmune encephalomyelitis (EAE). We show that late in the course of disease, EAE severity could not be reduced with a potent relapse inhibitor, FTY720 (fingolimod), indicating that disease was relapse-independent. During this same phase of disease, treatment with a BTK inhibitor reduced both EAE severity and demyelination compared to vehicle treatment. Compared to vehicle treatment, late therapeutic BTK inhibition resulted in fewer spinal cord-infiltrating myeloid cells, with lower expression of CD86, pro-IL-1β, CD206, and Iba1, and higher expression of Arg1, in both tissue-resident and infiltrating myeloid cells, suggesting a less inflammatory myeloid cell milieu. These changes were accompanied by decreased spinal cord axonal damage. We show similar efficacy with two small molecule inhibitors, including a novel, highly selective, central nervous system-penetrant BTK inhibitor, GB7208. These results suggest that through lymphoid and myeloid cell regulation, BTK inhibition reduced neurodegeneration and disease progression during secondary progressive EAE. [ABSTRACT FROM AUTHOR]